We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-0.65%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10.7B
AUM Growth
-$506M
Cap. Flow
-$174M
Cap. Flow %
-1.63%
Top 10 Hldgs %
9.5%
Holding
932
New
60
Increased
296
Reduced
331
Closed
64

Top Buys

Rank Stock Value
1
MRX
Marex Group Limited Ordinary Shares
MRX
+$25.9M
2
ENOV icon
Enovis
ENOV
+$23.7M
3
BANC icon
Banc of California
BANC
+$21.4M
4
ASO icon
Academy Sports + Outdoors
ASO
+$21.3M
5
ATKR icon
Atkore
ATKR
+$19M

Top Sells

Rank Stock Value
1
FORM icon
FormFactor
FORM
+$30.5M
2
IBTX
Independent Bank Group, Inc.
IBTX
+$25.4M
3
LECO icon
Lincoln Electric
LECO
+$21.7M
4
FTAI icon
FTAI Aviation
FTAI
+$21.1M
5
ARES icon
Ares Management
ARES
+$20.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.1%
2 Technology 20.67%
3 Financials 13.36%
4 Consumer Discretionary 11.61%
5 Healthcare 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
751
Cytokinetics
CYTK
$10.6B
$772K 0.01%
14,250
– –
SCHW
752
Charles Schwab
SCHW
$182B
$757K 0.01%
10,270
– –
INVA icon
753
Innoviva
INVA
$1.6B
$730K 0.01%
44,494
-24,612
-36% -$382K
HSII
754
DELISTED
Heidrick & Struggles
HSII
$724K 0.01%
22,924
+5,434
+31% +$177K
GFF icon
755
Griffon
GFF
$4.02B
$718K 0.01%
11,250
– –
PINC
756
DELISTED
Premier
PINC
$718K 0.01%
38,432
– –
CASH icon
757
Pathward Financial
CASH
$1.88B
$714K 0.01%
12,614
+5,039
+67% +$265K
CPF icon
758
Central Pacific Financial
CPF
$1.02B
$708K 0.01%
33,406
-18,190
-35% -$367K
CVSA
759
Covista Inc
CVSA
$4.55B
$705K 0.01%
10,330
– –
CMP icon
760
Compass Minerals
CMP
$1.23B
$698K 0.01%
67,609
– –
ARCH
761
DELISTED
Arch Resources, Inc.
ARCH
$694K 0.01%
+4,561
New +$733K
JXN icon
762
Jackson Financial
JXN
$8.4B
$692K 0.01%
+9,318
New +$666K
MBC icon
763
MasterBrand
MBC
$1.09B
$675K 0.01%
+45,968
New +$761K
VSTO
764
DELISTED
Vista Outdoor Inc.
VSTO
$671K 0.01%
17,827
-2,925
-14% -$101K
CTKB icon
765
Cytek Biosciences
CTKB
$566M
$667K 0.01%
119,478
+108,128
+953% +$649K
MODV
766
DELISTED
ModivCare
MODV
$656K 0.01%
25,000
-1,736
-6% -$43.9K
CALM icon
767
Cal-Maine
CALM
$4.43B
$653K 0.01%
+10,693
New +$634K
TLS icon
768
Telos
TLS
$331M
$648K 0.01%
+161,184
New +$612K
EVTC icon
769
Evertec
EVTC
$1.97B
$648K 0.01%
19,483
-9,052
-32% -$327K
ATRI
770
DELISTED
Atrion Corp
ATRI
$637K 0.01%
1,407
– –
PARR icon
771
Par Pacific Holdings
PARR
$4.17B
$632K 0.01%
25,034
– –
ENFN
772
DELISTED
Enfusion, Inc.
ENFN
$628K 0.01%
+73,670
New +$674K
HURC icon
773
Hurco Companies Inc
HURC
$132M
$617K 0.01%
40,445
-225,925
-85% -$4.07M
UPLD icon
774
Upland Software
UPLD
$13.3M
$608K 0.01%
24,410
– –
ASTH icon
775
Astrana Health
ASTH
$1.81B
$607K 0.01%
14,968
– –
29 30
31
32 33

Similar funds

GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $9.98B AUM 4.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Royce & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Royce & Associates held 932 positions worth $10.7B, down 4.5% from $11.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates's Q2 2024 filing shows 60 new, 296 increased, 331 reduced and 64 closed positions. Its largest new stake was Marex Group Limited Ordinary Shares: 1,319,744 shares worth $26.4M. The largest sale was FormFactor, an estimated $30.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2024 buy was Marex Group Limited Ordinary Shares: 1,319,744 shares worth $26.4M.
  • Royce & Associates added most to Enovis in Q2 2024, an estimated $23.7M increase.
  • Royce & Associates's biggest Q2 2024 reduction was FormFactor, cutting an estimated $30.5M.
  • Royce & Associates fully exited Valley National Bancorp in Q2 2024, selling an estimated $18M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $10.7B portfolio in Q2 2024.
  • Royce & Associates opened 60 new positions and closed 64 in Q2 2024.
  • Royce & Associates's portfolio value fell 4.5% quarter-over-quarter to $10.7B.

Based on Royce & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.